Aspenwood Capital Raises $3.5 Million for LifeVantage Corporation

SAN DIEGO--(Business Wire)--
LifeVantage Corporation (OTCBB: LFVN) announced today that Aspenwood Capital
(www.AspenwoodCapital.com), a Denver-based investment bank, has completed a $3.5
million private placement for the Company to accredited investors. LifeVantage
(www.LifeVantage.com) is a science-based, natural products company dedicated to
helping people reach their health and wellness goals through science-based
solutions to oxidative stress. LifeVantage is the maker of Protandim® - a
dietary supplement clinically shown to induce the body`s own antioxidant
defenses, and is developing an entire product line for its network marketing
program.

Aspenwood Capital partner Steve Ossello said, "As active investment bankers for
LifeVantage over the past several years, we have always been tremendous
supporters of the company and its primary product - Protandim®. This capital
raising effort is particularly gratifying now that the company's exciting new
network marketing strategy should provide Protandim® with the distribution it
richly deserves."

LifeVantage CEO and President David Brown said, "We are extremely pleased with
the success of this raise. This vote of confidence from investors is an
excellent reflection on the direction of the Company and the many exciting
developments that have recently occurred. The proceeds from this financing
should allow the Company to accomplish several goals, including the expansion of
our infrastructure and marketing efforts for our network marketing program."

About Aspenwood Capital

Aspenwood Capital (www.AspenwoodCapital.com) of Denver, Colo., a division of
Colorado Financial Services Corporation (member FINRA / SIPC), specializes in
providing investment banking services to small-cap public issuers and late-stage
private companies.

About Protandim®

Protandim® is a groundbreaking, clinically proven supplement that provides a
substantial benefit to help with the challenge of healthy aging. This patented
antioxidant therapy is more powerful than conventional foods such as red wine,
oranges, blueberries or other popular antioxidant supplements. Protandim® works
by increasing the body`s natural antioxidant protection at the cellular level,
triggering cells to produce naturally occurring protective antioxidant enzymes
such as superoxide dismutase (SOD), catalase and glutathione.

A peer-reviewed human study showed that after Protandim® was taken for 30
consecutive days, the accumulation of lipid peroxidation products (a biochemical
marker of aging) was decreased by an average of 40%. The study also reported
that this important marker of aging was decreased after taking Protandim® to the
level of a typical 20 year old. Protandim® is currently the subject of over 20
scientific studies at leading universities and research institutes. For more
information, please visitwww.LifeVantage.com.

About LifeVantage Corporation

LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science-based,
natural products company dedicated to helping people reach their health and
wellness goals through science-based solutions to oxidative stress. Founded in
2003 and based in San Diego, Calif., LifeVantage develops nutraceutical
products, including Protandim®, that leverage the company's expertise and that
are intended to deliver significant health benefits to consumers. For more
information, visit www.LifeVantage.com.

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.The
Company uses the words "anticipate," "believe," "could," "should," "estimate,"
"expect," "intend," "may," "predict," "project," "plan," "target" and similar
terms and phrases, including references to assumptions, to identify
forward-looking statements.These forward-looking statements are based on the
Company`s current expectations and beliefs concerning future events affecting
the Company and involve known and unknown risks and uncertainties that may cause
the Company's actual results or outcomes to be materially different from those
anticipated and discussed herein.These risks and uncertainties include, among
others, the risk that government regulators and regulations could adversely
affect our business; future laws or regulations may hinder or prohibit the
production or sale of our existing product and any future products; unfavorable
publicity could materially hurt our business; and the Company`s ability to
protect our intellectual property rights and the value of our product.These and
other risk factors are discussed in greater detail in the Company`s Annual
Report on Form 10-KSB under the caption "Risk Factors," and in other documents
filed the Company from time to time with the Securities and Exchange
Commission.The Company cautions investors not to place undue reliance on the
forward-looking statements contained in this document.All forward-looking
statements are based on information currently available to the Company on the
date hereof, and the Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after the date of
this document, except as required by law.

*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.

Note to Editors: Contact Patrick Courtemanche at 612-746-1776 or
pat_court@yahoo.com for interviews, photography, and other requests.

LifeVantage
Patrick Courtemanche, 612-746-1776
pat_court@yahoo.com
or
Aspenwood Capital
Steve J. Ossello, 720-533-4888, ext. 1
sossello@aspenwoodcapital.com

Copyright Business Wire 2009